FibroBiologics, Inc.

10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Delisting notice or listing-rule failure Jul 24, 2026 8-K Director or officer change; Regulation FD disclosure Jul 9, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jun 29, 2026 8-K Director or officer change; Shareholder vote results Jun 23, 2026 8-K Entered a material agreement May 6, 2026 8-K Director or officer change May 5, 2026 8-K Entered a material agreement May 1, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Regulation FD disclosure; Other events Apr 20, 2026 8-K Amended charter or bylaws Apr 17, 2026 8-K/A Entered a material agreement; Terminated a material agreement; Other events Apr 9, 2026 8-K Entered a material agreement; Other events Apr 9, 2026 8-K Modified rights of security holders; Amended charter or bylaws Apr 3, 2026 8-K Entered a material agreement; Regulation FD disclosure Apr 2, 2026 10-K/A Fiscal year ended 2025-12-31 Mar 13, 2026 8-K Director or officer change Mar 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Shareholder vote results Feb 23, 2026 8-K Delisting notice or listing-rule failure Feb 6, 2026 8-K Delisting notice or listing-rule failure Jan 2, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Nov 25, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events Nov 19, 2025 10-Q Quarter ended 2025-09-30 Oct 31, 2025 8-K Delisting notice or listing-rule failure Aug 8, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K/A Unregistered sale of equity Jul 18, 2025 8-K Unregistered sale of equity Jul 18, 2025 8-K Delisting notice or listing-rule failure Jul 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Jun 16, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 13, 2025 8-K Director or officer change; Regulation FD disclosure Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Director or officer change May 5, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Unregistered sale of equity Feb 7, 2025 8-K Director or officer change Jan 24, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Dec 31, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Dec 23, 2024